42936 pathogens from Canadian hospitals: 10 years of results (2007–16) from the CANWARD surveillance study

Infectious Diseases Physicians: Leading the Way in Antimicrobial Stewardship

(2018) Belinda Ostrowsky et al.   CLINICAL INFECTIOUS DISEASES

Antimicrobial activity of ceftobiprole and comparator agents when tested against contemporary Gram-positive and -negative organisms collected from Europe (2015)

(2018) M.A. Pfaller et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

Prioritizing a One Health Approach in the Immediate Fight Against Antimicrobial Resistance

(2018) V. Ayano Ogawa et al.   EcoHealth

Surveillance of tigecycline activity tested against clinical isolates from a global (North America, Europe, Latin America and Asia-Pacific) collection (2016)

(2018) Michael A. Pfaller et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party†

(2018) Peter M Hawkey et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Global increase and geographic convergence in antibiotic consumption between 2000 and 2015

(2018) Eili Y. Klein et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

First WHO antimicrobial surveillance data reveal high levels of resistance globally

(2018) Susan Mayor   BMJ-British Medical Journal

First WHO antimicrobial surveillance data reveal high levels of resistance globally

(2018) Susan Mayor   BMJ-British Medical Journal

In vitro activity of plazomicin against β-lactamase-producing carbapenem-resistant Enterobacteriaceae (CRE)

(2017) Yunliang Zhang et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Prevalence of carbapenem resistance and carbapenemase production among Enterobacteriaceae isolated from urine in the UK: results of the UK infection-Carbapenem Resistance Evaluation Surveillance Trial (iCREST-UK)

(2017) Neil Woodford et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

In vitro activity of ceftolozane/tazobactam versus antimicrobial non-susceptible Pseudomonas aeruginosa clinical isolates including MDR and XDR isolates obtained from across Canada as part of the CANWARD study, 2008–16

(2017) Andrew Walkty et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Activities of Tedizolid and Linezolid Determined by the Reference Broth Microdilution Method against 3,032 Gram-Positive Bacterial Isolates Collected in Asia-Pacific, Eastern Europe, and Latin American Countries in 2014

(2016) Michael A. Pfaller et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Surveillance for linezolid resistance via the Zyvox®Annual Appraisal of Potency and Spectrum (ZAAPS) programme (2014): evolving resistance mechanisms with stable susceptibility rates

(2016) Rodrigo E. Mendes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Longitudinal (2001–14) analysis of enterococci and VRE causing invasive infections in European and US hospitals, including a contemporary (2010–13) analysis of oritavancin in vitro potency

(2016) Rodrigo E. Mendes et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Telavancin activity tested against Gram-positive clinical isolates from European, Russian and Israeli hospitals (2011–2013) using a revised broth microdilution testing method: redefining the baseline activity of telavancin

(2016) Rodrigo E. Mendes et al.   JOURNAL OF CHEMOTHERAPY

A Preliminary Guideline for the Assignment of Methicillin-ResistantStaphylococcus aureusto a Canadian Pulsed-Field Gel Electrophoresis Epidemic Type UsingspaTyping

(2016) George R Golding et al.   Canadian Journal of Infectious Diseases & Medical Microbiology

Epidemiology of Vancomycin-Resistant Enterococci in Canadian Hospitals (CANWARD Study, 2007 to 2013)

(2015) P. J. Simner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Telavancin: Mechanisms of Action, In Vitro Activity, and Mechanisms of Resistance

(2015) James A. Karlowsky et al.   CLINICAL INFECTIOUS DISEASES

Tedizolid: A Novel Oxazolidinone with Potent Activity Against Multidrug-Resistant Gram-Positive Pathogens

(2015) George G. Zhanel et al.   DRUGS

Analysis of 5-year trends in daptomycin activity tested against Staphylococcus aureus and enterococci from European and US hospitals (2009–2013)

(2015) Helio S. Sader et al.   Journal of Global Antimicrobial Resistance

Changing epidemiology of methicillin-resistant Staphylococcus aureus in Canada

(2013) K. A. Nichol et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Antimicrobial susceptibility of 22746 pathogens from Canadian hospitals: results of the CANWARD 2007-11 study

(2013) G. G. Zhanel et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Molecular epidemiology of extended-spectrum  -lactamase-, AmpC  -lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11

(2013) A. J. Denisuik et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Comparison of the next-generation aminoglycoside plazomicin to gentamicin, tobramycin and amikacin

(2012) George G Zhanel et al.   Expert Review of Anti-Infective Therapy

Ceftobiprole

(2009) George G Zhanel et al.   AMERICAN JOURNAL OF CLINICAL DERMATOLOGY